Publication: What predicts the recurrence in idiopathic granulomatous mastitis?
dc.contributor.author | Lermi, Nihal | |
dc.contributor.author | Ekin, Ali | |
dc.contributor.author | Ocak, Tuğba | |
dc.contributor.author | Bozkurt, Zeynep Yılmaz | |
dc.contributor.author | Ötegeçeli, Mehmet Akif | |
dc.contributor.author | Yağız, Burcu | |
dc.contributor.author | Coşkun, Belkıs Nihan | |
dc.contributor.author | Pehlivan, Yavuz | |
dc.contributor.author | Dalkılıç, Ediz | |
dc.contributor.buuauthor | LERMİ, NİHAL | |
dc.contributor.buuauthor | EKİN, ALİ | |
dc.contributor.buuauthor | OCAK, TUĞBA | |
dc.contributor.buuauthor | Bozkurt, Zeynep Yılmaz | |
dc.contributor.buuauthor | ÖTEGEÇELİ, MEHMET AKİF | |
dc.contributor.buuauthor | YAĞIZ, BURCU | |
dc.contributor.buuauthor | COŞKUN, BELKIS NİHAN | |
dc.contributor.buuauthor | PEHLİVAN, YAVUZ | |
dc.contributor.buuauthor | DALKILIÇ, HÜSEYİN EDİZ | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | İç Hastalıkları Ana Bilim Dalı | |
dc.contributor.orcid | 0000-0003-3692-1293 | |
dc.contributor.orcid | 0000-0003-3692-1293 | |
dc.contributor.orcid | 0000-0002-7714-7786 | |
dc.contributor.researcherid | GXH-1905-2022 | |
dc.contributor.researcherid | JQW-5031-2023 | |
dc.contributor.researcherid | AAG-7155-2021 | |
dc.contributor.researcherid | FGB-0552-2022 | |
dc.contributor.researcherid | FPM-3131-2022 | |
dc.contributor.researcherid | IUR-9292-2023 | |
dc.contributor.researcherid | IUS-1387-2023 | |
dc.contributor.researcherid | IRX-3951-2023 | |
dc.contributor.researcherid | JHC-5173-2023 | |
dc.date.accessioned | 2024-09-13T10:56:49Z | |
dc.date.available | 2024-09-13T10:56:49Z | |
dc.date.issued | 2023-06-10 | |
dc.description.abstract | Introduction Idiopathic granulomatous mastitis (IGM) is a rarely seen chronic and benign disease of the breast. IGM usually emerges in women between 30 and 45 years of age and within the first 5 years after lactation. There is no consensus on the treatment of the disease. Steroids, immunosuppressive agents such as methotrexate and azathioprine, antibiotics, and surgical and conservative treatments can be preferred. In the present study, it was aimed to demonstrate the treatment options and follow-up data of the patients with IGM and to investigate the effective factors on recurrence if developed in the follow-up period.Materials and method The data of 120 patients diagnosed with idiopathic granulomatous mastitis were evaluated for this cross-sectional retrospective study. The demographic, clinical, treatment, and follow-up features of the patients were obtained from the file records.Results The median age value of the 120 female patients included in the study was 35 (24-67) years. Of the patients, 45%, 79.2%, 49.2%, and 15% had a past history of surgical intervention, steroid use, methotrexate use, and azathioprine use, respectively. Recurrent lesion developed after the treatment in 57 (47.5%) patients. The recurrence rate was 66.1% in the patients who underwent surgical intervention in the initial treatment. There was a statistically significant difference between the patients with and without recurrence regarding the presence of abscess, the presence of recurrent abscess, and having surgical intervention as the initial treatment in the past history. The rate of having surgery was statistically significantly higher compared with the administration of steroid therapy alone and the combination of steroid and immunosuppressive therapy in the initial treatment of the patients who developed recurrence. The rate of having surgery together with the administration of steroid and immunosuppressive therapy was statistically significantly higher than the administration of steroid and immunosuppressive therapies.Discussion Our study showed that surgical intervention and the presence of abscess increased recurrence in the treatment of IGM. | |
dc.identifier.doi | 10.1007/s10067-023-06651-3 | |
dc.identifier.endpage | 2500 | |
dc.identifier.issn | 0770-3198 | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | 2491 | |
dc.identifier.uri | https://doi.org/10.1007/s10067-023-06651-3 | |
dc.identifier.uri | https://link.springer.com/article/10.1007/s10067-023-06651-3 | |
dc.identifier.uri | https://hdl.handle.net/11452/44718 | |
dc.identifier.volume | 42 | |
dc.identifier.wos | 001006722600001 | |
dc.indexed.wos | WOS.SCI | |
dc.language.iso | en | |
dc.publisher | Springer London Ltd | |
dc.relation.journal | Clinical Rheumatology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Surgical-treatment | |
dc.subject | Lobular mastitis | |
dc.subject | Methotrexate | |
dc.subject | Experience | |
dc.subject | Management | |
dc.subject | Disease | |
dc.subject | Update | |
dc.subject | Idiopathic granulomatous mastitis | |
dc.subject | Methotrexate | |
dc.subject | Recurrence | |
dc.subject | Surgery | |
dc.subject | Treatment | |
dc.subject | Rheumatology | |
dc.title | What predicts the recurrence in idiopathic granulomatous mastitis? | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Romatoloji Ana Bilim Dalı | |
local.contributor.department | Tıp Fakültesi/İç Hastalıkları Ana Bilim Dalı | |
relation.isAuthorOfPublication | 7ab3d335-65f4-4ed0-9232-2cb5eece4f77 | |
relation.isAuthorOfPublication | ee3ea25a-1fdc-4876-b08e-2b6a76d20984 | |
relation.isAuthorOfPublication | 6cb92e7a-17de-4006-944d-e9339a2b4591 | |
relation.isAuthorOfPublication | 97e6fb0b-7225-43f7-8566-88e8486892aa | |
relation.isAuthorOfPublication | 02b3cfbb-e8e7-4a95-b025-294888ae9a91 | |
relation.isAuthorOfPublication | faabfe30-a620-4cbe-8b6d-3db71b10ce0e | |
relation.isAuthorOfPublication | 0075f2ae-ae8a-4690-bd46-128775e8efac | |
relation.isAuthorOfPublication | 1613225c-2f43-4052-9f82-210c854edcf4 | |
relation.isAuthorOfPublication.latestForDiscovery | 7ab3d335-65f4-4ed0-9232-2cb5eece4f77 |